Jane J. Zara

Array ( [id] => 7216482 [patent_doc_number] => 20050260166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Expressional enhancers from viruses' [patent_app_type] => utility [patent_app_number] => 11/107315 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11177 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260166.pdf [firstpage_image] =>[orig_patent_app_number] => 11107315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062561 [patent_doc_number] => 20070224200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Gm3 Synthase as a Therapeutic Target in Microvascular Complications of Diabetes' [patent_app_type] => utility [patent_app_number] => 11/579725 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10212 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224200.pdf [firstpage_image] =>[orig_patent_app_number] => 11579725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5156189 [patent_doc_number] => 20070039072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Functional and hyperfunctional siRNA' [patent_app_type] => utility [patent_app_number] => 11/093832 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 49885 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20070039072.pdf [firstpage_image] =>[orig_patent_app_number] => 11093832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 795554 [patent_doc_number] => 07429468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Mutant B-type DNA polymerases exhibiting improved performance in PCR' [patent_app_type] => utility [patent_app_number] => 11/077886 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6222 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/429/07429468.pdf [firstpage_image] =>[orig_patent_app_number] => 11077886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651093 [patent_doc_number] => 20080038349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase' [patent_app_type] => utility [patent_app_number] => 10/589755 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9915 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038349.pdf [firstpage_image] =>[orig_patent_app_number] => 10589755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10115734 [patent_doc_number] => 09150606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Compositions comprising alternating 2\'-modified nucleosides for use in gene modulation' [patent_app_type] => utility [patent_app_number] => 11/054848 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36064 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11054848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200182 [patent_doc_number] => 20050164974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Nucleic acid ligand complexes' [patent_app_type] => utility [patent_app_number] => 11/050017 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 23121 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164974.pdf [firstpage_image] =>[orig_patent_app_number] => 11050017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912291 [patent_doc_number] => 20050176049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Detecting surface to detect interaction between substances, sensor chip and sensing device equipped with detecting surface, and detecting method' [patent_app_type] => utility [patent_app_number] => 11/050560 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6415 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176049.pdf [firstpage_image] =>[orig_patent_app_number] => 11050560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945260 [patent_doc_number] => 20050197309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Antisense modulation of dual specific phosphatase 5 expression' [patent_app_type] => utility [patent_app_number] => 11/035809 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25244 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197309.pdf [firstpage_image] =>[orig_patent_app_number] => 11035809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7043023 [patent_doc_number] => 20050160490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods and means for producing efficient silencing construct using recombinational cloning' [patent_app_type] => utility [patent_app_number] => 11/033553 [patent_app_country] => US [patent_app_date] => 2005-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13175 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20050160490.pdf [firstpage_image] =>[orig_patent_app_number] => 11033553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263771 [patent_doc_number] => 07569536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity' [patent_app_type] => utility [patent_app_number] => 10/584482 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 31717 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569536.pdf [firstpage_image] =>[orig_patent_app_number] => 10584482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211547 [patent_doc_number] => 07622453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Oligomeric compounds for the modulation of Bcl-2' [patent_app_type] => utility [patent_app_number] => 11/021729 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 26627 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622453.pdf [firstpage_image] =>[orig_patent_app_number] => 11021729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270648 [patent_doc_number] => 07563884 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Antisense modulation of PTP1B expression' [patent_app_type] => utility [patent_app_number] => 11/008747 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28842 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563884.pdf [firstpage_image] =>[orig_patent_app_number] => 11008747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918731 [patent_doc_number] => 20050096292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Notch1 inhibitors for inducing apoptosis' [patent_app_type] => utility [patent_app_number] => 10/991147 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31413 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096292.pdf [firstpage_image] =>[orig_patent_app_number] => 10991147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098468 [patent_doc_number] => 20050130927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Antisense oligonucleotide preparation method' [patent_app_type] => utility [patent_app_number] => 10/984919 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 6969 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130927.pdf [firstpage_image] =>[orig_patent_app_number] => 10984919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085868 [patent_doc_number] => 20070275919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Rna Amidates and Thioamidates for Rnai' [patent_app_type] => utility [patent_app_number] => 10/578530 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12707 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275919.pdf [firstpage_image] =>[orig_patent_app_number] => 10578530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5774676 [patent_doc_number] => 20050268351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Modulation of storage organs' [patent_app_type] => utility [patent_app_number] => 10/981029 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8111 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20050268351.pdf [firstpage_image] =>[orig_patent_app_number] => 10981029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253303 [patent_doc_number] => 20070134759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Process for producing antibody composition by using rna inhibiting the function of alpha1,6-fucosyltransferase' [patent_app_type] => utility [patent_app_number] => 10/575096 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 42087 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134759.pdf [firstpage_image] =>[orig_patent_app_number] => 10575096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7142969 [patent_doc_number] => 20050118253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Systemic delivery of serum stable plasmid lipid particles for cancer therapy' [patent_app_type] => utility [patent_app_number] => 10/954858 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16001 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118253.pdf [firstpage_image] =>[orig_patent_app_number] => 10954858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136592 [patent_doc_number] => 20050181385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Synthetic lethal screen using RNA interference' [patent_app_type] => utility [patent_app_number] => 10/947637 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 79121 [patent_no_of_claims] => 218 [patent_no_of_ind_claims] => 52 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181385.pdf [firstpage_image] =>[orig_patent_app_number] => 10947637 [rel_patent_id] =>[rel_patent_doc_number] =>)